Internal Medicine · Forest Hills, NY
NPI
1558458356
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
2
Hospital affiliations
11510 Queens Blvd Ste Ul8
Forest Hills, NY, 11375
Phone (718) 263-8282
Medicare paid, 2024
$426K
7,116 services
Medicare patients, 2024
339
Average age 76
Drug cost, 2024
$3.1M
12,541 prescriptions
Company payments, 2025
$1,031
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vladimir Gabay was code 99213 (office e&m - established), 1,624 times for 294 patients. In total Vladimir Gabay billed 7,116 services in 48 codes, and Medicare paid $426K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,624 | 294 | $75.21 | $122K |
| 36415 Venipuncture Blood Collection | Office | 767 | 313 | $8.63 | $6,617 |
| 93000 Electrocardiogram | Office | 489 | 303 | $12.59 | $6,158 |
| 99214 Office E&M - Established | Office | 404 | 287 | $95.31 | $39K |
| 71046 X-ray - Chest | Office | 337 | 247 | $30.25 | $10K |
| 81002 Clinical Chemistry | Office | 325 | 233 | $3.40 | $1,105 |
| 95921 Electrical Nerve Conductivity | Office | 307 | 245 | $79.45 | $24K |
| 95923 Electrical Nerve Conductivity | Office | 307 | 245 | $101.05 | $31K |
| 94060 Pulmonary Function Testing | Office | 298 | 240 | $34.59 | $10K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 205 | 205 | $145.86 | $30K |
| 93923 Duplex Scan - Extremity Arteries | Office | 178 | 177 | $114.81 | $20K |
| 92547 Vision, Hearing, and Speech Services | Office | 164 | 164 | $9.96 | $1,633 |
| 92540 Vision, Hearing, and Speech Services | Office | 164 | 164 | $94.69 | $16K |
| 92546 Vision, Hearing, and Speech Services | Office | 164 | 164 | $116.54 | $19K |
| 99232 Hospital E&M - Subsequent | Facility | 163 | 25 | $68.15 | $11K |
By year: 2022 $426K for 6,837 services; 2023 $492K for 7,982 services; 2024 $426K for 7,116 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 767 | 313 | $8.63 | $6,617 |
| 81002 Clinical Chemistry | 325 | 233 | $3.40 | $1,105 |
Medicare prescription drug claims, 2024
In 2024, the drug Vladimir Gabay prescribed most often to Medicare patients was Amlodipine Besylate, with 507 prescriptions and refills. In total Vladimir Gabay wrote 12,541 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 507 | 1,185 | 129 | $2,051 |
| Atorvastatin Calcium Generic | 417 | 968 | 98 | $2,524 |
| Rosuvastatin Calcium Generic | 323 | 591 | 65 | $2,638 |
| Metoprolol Succinate Generic | 316 | 724 | 80 | $4,194 |
| Losartan Potassium Generic | 308 | 728 | 77 | $2,532 |
| Montelukast Sodium Generic | 294 | 549 | 80 | $1,854 |
| Diclofenac Sodium Generic | 287 | 301 | 31 | $153K |
| Levothyroxine Sodium Generic | 267 | 652 | 65 | $2,815 |
| Zolpidem Tartrate Generic | 208 | 210 | 33 | $1,068 |
| Gabapentin Generic | 195 | 250 | 56 | $1,641 |
| Tamsulosin Hcl Generic | 172 | 310 | 37 | $1,599 |
| Linzess Linaclotide | 170 | 196 | 30 | $99K |
| Omeprazole Generic | 169 | 301 | 44 | $1,334 |
| Vascepa Icosapent Ethyl | 168 | 212 | 23 | $71K |
| Synthroid Levothyroxine Sodium | 160 | 359 | 36 | $14K |
Brand drugs: 3,448 claims; generic drugs: 8,964 claims; opioid claims: 73.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vladimir Gabay $1,031 ($1,031 in general payments such as food, travel and fees) from 12 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $205.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 10 | $205 |
| Kowa Pharmaceuticals America, Inc. | 7 | $175 |
| Incyte Corporation INCY | 7 | $137 |
| Aimmune Therapeutics, Inc. | 3 | $133 |
| Abbvie Inc. ABBV | 4 | $91.76 |
| Amgen Inc. AMGN | 3 | $60.19 |
| Genzyme Corporation SNY | 2 | $54.82 |
| Axsome Therapeutics, Inc. AXSM | 2 | $54.67 |
| Lilly USA, LLC LLY | 2 | $40.29 |
| Pfizer Inc. PFE | 1 | $29.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.